Pharma Paying Billions for Fraud and Illegal Marketing Practices

[Leslie Carol Botha: It is about time that the fraud and deception on medical consumers who believe in their government and the medical industry comes to a halt. The cost and damage to people’s lives is astronomical.  If you want to know what pharma reps are saying about their own industry go to Cafe Pharma

Here’s just one example:

Idiot. Its the same reason all other drugs are sold. Profit. “Cure” breast cancer and you can charge what its WORTH..think total (not just drug) costs for a terminal breast cancer patient. I have no idea what that number is but SWAG it at $500k.

“Cure” it and you can charge $400k, save the “system” $100k and more importantly save the individual’s life. Whats that WORTH?

More drug companies to pay billions for fraud, join the “dishonor roll” after Abbott settlement

Kelton writes about whistleblower matters involving fraud and other issues.


Forbes Magazine
Erika Kelton
, Contributor
May 12, 2012


With Abbott’s $1.5 billion settlement of a whistleblower-initiated  case this week, Abbott joins an infamous list of pharma companies that have paid more than one billion dollars to the federal government for illegal marketing practices, including promoting prescription drugs for uses not approved by the FDA, paying financial inducements to increase sales and engaging in practices that pose grave danger to patients’ health and lives.

This dishonor roll includes pharma giants Pfizer, which paid $2.3 billion to the government in 2009, and Eli Lilly, which settled civil and criminal charges earlier in 2009 for $1.4 billion.

Soon there will be more additions to pharma’s billion-dollar-plus club: GlaxoSmithKline announced last November that it had reached an agreement in principle to pay $3 billion this year to resolve multiple government investigations into its sales and marketing practices. And Johnson & Johnson (J&J ) reportedly is in negotiations with the government to pay more than $1 billion to settle civil charges for the off-label marketing of Risperdal and Invega.

Meanwhile, Amgen said last Octoberthat it had reached an agreement in principle to pay $780 million to settle litigation involving state Medicaid investigations and 10 “qui tam” (whistleblower) lawsuits involving illegal marketing practices.



Despite the prosecutions, huge fines and bad publicity, too many pharma companies have failed to change their ways. Billion-dollar settlements are to some just the cost of doing business. At my firm, we continue to see a steady stream of whistleblowers with powerful evidence of pharma wrongdoing – be it illegal promotion of prescription drugs; financial inducements to doctors and pharmacists to prescribe or sell certain prescription drugs; manufacturing practices that contaminate drugs;  and the use of phony science to support FDA approval or shady  marketing, to name just a few.

Read Full Article…


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.